Key Record Dates
ClinicalTrials.gov Identifier: | NCT02132624 |
---|---|
Brief Title: | CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial. |
First Submitted : | May 5, 2014 |
First Submitted that Met QC Criteria : | May 5, 2014 |
First Posted : | May 7, 2014 (Estimate) |
Last Update Submitted that Met QC Criteria : | October 27, 2017 |
Last Update Posted : | October 30, 2017 |